| Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits. | |
| | |
MedLine Citation:
|
PMID: 21785628 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Atherosclerosis which results from gradual deposition of lipids in medium and large arteries is a leading cause of mortality worldwide. Terminalia arjuna is a herb of Combretaceae family which contains hypolipidemic compounds and flavonoids with high antioxidative properties. This study was conducted to determine the effect of ethanolic fraction of T. arjuna on blood lipids and atherosclerosis in rabbits fed with high fat diet (HFD). Twenty New Zealand rabbits of either sex were randomly divided into five groups: the first two were normal diet group and HFD (21% fat) group and the remaining three groups received high cholesterol diet supplemented with standard drug (Atorvastatin 10 mg kg(-1) body weight), T. arjuna ethanolic fraction (100 and 200 mg kg(-1) body weight), respectively. The concentration of total cholesterol (TC), low density lipoprotein (LDL) cholesterol, triglycerides (TGs), very low density lipoprotein (VLDL) cholesterol and high density lipoprotein (HDL) cholesterol was determined in rabbits at the start of the experiment, at the 14th, 30th days and at the end of the study. Anti-atherogenic index was calculated from the lipid profile of the rabbits before sacrifice. At the end of the experimental period, the aorta was removed for assessment of atherosclerotic plaques. Results show that T. arjuna significantly decreases TC, LDL and TG levels and increases HDL and lessens atherosclerotic lesion in aorta (P < .05). Hence T. arjuna extract can effectively prevent the progress of atherosclerosis. This is likely due to the effect of T. arjuna on serum lipoproteins and its antioxidant and anti-inflammatory properties. |
| | |
Authors:
|
Saravanan Subramaniam; Ramachandran Subramaniam; Suja Rajapandian; Subasini Uthrapathi; Victor Rajamanickam Gnanamanickam; Govinda Prasad Dubey |
Related Documents
:
|
2597228 - Dyslipoproteinemia in murine systemic lupus erythematosus. 8169998 - Biochemical effects of manufactured gas plant residue following ingestion by b6c3f1 mice. 19735918 - Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in a... 20233938 - Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. 3226358 - Is malnutrition necessary for the development of alcoholic fatty liver in the rat? 16476868 - Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk fac... |
Publication Detail:
|
Type: Journal Article Date: 2011-03-20 |
Journal Detail:
|
Title: Evidence-based complementary and alternative medicine : eCAM Volume: 2011 ISSN: 1741-4288 ISO Abbreviation: Evid Based Complement Alternat Med Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-07-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101215021 Medline TA: Evid Based Complement Alternat Med Country: United States |
Other Details:
|
Languages: eng Pagination: 487916 Citation Subset: - |
Affiliation:
|
Department of Pharmacology and Toxicology, PSG College of Pharmacy, PSG Institute of Medical Science and Research, Peelamedu, Coimbatore 641 004, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ameliorate Effects of Li-Fu Formula on IL-6-Mediated Cardiac Hypertrophy in Hamsters Fed with a Hype...
Next Document: Assessment of Antioxidant Properties in Fruits of Myrica esculenta: A Popular Wild Edible Species in...